Most canine tumors are follicular (FTC) or medullary carcinomas (MTC), unlike humans, where only 10–15% are FTC and 2% are MTC, with BRAF/NRAS or RET mutations, respectively. The gene discussed is NRAS; the disease is thyroid cancer, nonmedullary, 2.